CureMetrix
PrivateLast Round
Series C
Sep 17, 2024
Total Funding Raised
$30M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CureMetrix operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series C round in September 2024.
CureMetrix is a healthcare technology company that develops artificial intelligence-based software for medical image analysis, primarily focused on mammography and breast health.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CureMetrix Comparables
Compare CureMetrix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Whiterabbit.ai | 87% | |
| Densitas Inc. | 86% | |
| Therapixel | 84% |
For institutional investors. Book with your work email.
CureMetrix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 17, 2024 | ||||
| Seed | May 13, 2015 | ||||
| Accelerator | Aug 1, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CureMetrix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Analytics Ventures | Seed, Accelerator |
| EvoNexus | Accelerator, Seed |
| XB Ventures | Series C |
| Keshif Ventures | Seed, Accelerator |
| Unitleader | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 45% MoM.
- Jan 21, 2026
Monthly visitors increased 60% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withSep 1, 2026
CureMetrix, Inc. partnered with Suffolk Breast Imaging, PC on Sep 1st '26.
For institutional investors. Book with your work email.
CureMetrix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CureMetrix's valuation, stock price, and market status.
Is CureMetrix a public or private company?
CureMetrix is a private company.
What is the current stock price of CureMetrix?
CureMetrix is a private company, so its shares have no public market price. Caplight tracks CureMetrix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CureMetrix worth (valuation)?
Valuation information for CureMetrix is not publicly available.
Can I buy CureMetrix stock?
CureMetrix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CureMetrix's last funding round?
CureMetrix's most recent funding round was Series C on September 17, 2024.
Who are the main investors in CureMetrix?
Key investors in CureMetrix include Analytics Ventures, EvoNexus.
Will CureMetrix IPO soon?
No public IPO plans have been announced for CureMetrix.
How can I track CureMetrix secondary market activity?
Caplight tracks bids, offers, and trades in CureMetrix's shares on secondary markets.